Cyclodextrin, CAVAMAX®, CAVASOL®

Product Description

WACKER is the only company worldwide offering all three parent cyclodextrins, which are marketed under the trademark CAVAMAX®. WACKER also manufactures and offers chemically modified cyclodextrin derivatives, which are marketed under the trademark CAVASOL®. The modification of the guest with this molecular cage leads to the various applications of cyclodextrins. Complexes with CAVAMAX® cyclodextrins stabilize substances against heat, oxidation, UV light and enzymatic degradation. They mask odors or tastes, stabilizing oils, and much more. These complexes are compressible, water dispersible and easily formulated, and their particle size can be adjusted by grinding. Benefits of Cyclodextrin Inclusion Complexes: Increased bioavailability, Controlled release, Solubilization, Stabilization, Masking, Excipient, Auxiliary. To learn more visit: https://www.wacker.com/cms/en-de/products/product-groups/cyclodextrins-complexes/cyclodextrins-complexes.html

Wacker Biotech GmbH

  • DE
  • 2021
    On CPHI since
  • 5
    Certificates
  • 5000+
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Excipients Manufacturer
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer
Nutraceuticals
Specifications
  • CAS Registry Number
    7585-39-9

Wacker Biotech GmbH

  • DE
  • 2021
    On CPHI since
  • 5
    Certificates
  • 5000+
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Excipients Manufacturer
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer
Nutraceuticals